Amy A. Wolf

2.9k citations

40 papers · 2.2k · 2 hit papers · h-index 20

Impact in

Psychiatry and Mental health top 1%
- Dementia and Cognitive Impairment Research
Physiology top 2%
- Alzheimer's disease research and treatments

Papers in

Psychiatry and Mental health 27
- Dementia and Cognitive Impairment Research 27
Neurology 8
- Amyotrophic Lateral Sclerosis Research 6

Co-authors: Joel H. Kramer (21 shared papers)Kaitlin Blackstone Casaletto (14 shared papers)Samantha M. Walters (9 shared papers)Fanny M. Elahi (10 shared papers)Yann Cobigo (16 shared papers)Howard J. Rosen (10 shared papers)Bruce L. Miller (10 shared papers)Adam M. Staffaroni (15 shared papers)
Journals: Alzheimer s & Dementia (8 papers)Neurology (3 papers)JAMA Network Open (3 papers)Frontiers in Aging Neuroscience (2 papers)Nature Medicine (2 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

Amy A. Wolf

38 papers receiving 2.2k citations

Amy A. Wolf's Hit Papers

align trajectories log scale

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study 2021 · 449 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2021 The Lancet Neurology
2020 Nature Medicine

Peers

Countries citing papers authored by Amy A. Wolf

Since Specialization

Citations

This map shows the geographic impact of Amy A. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy A. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy A. Wolf more than expected).

Fields of papers citing papers by Amy A. Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy A. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy A. Wolf. The network helps show where Amy A. Wolf may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy A. Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy A. Wolf Line = papers co-authored together Amy A. Wolf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration Nature Medicine ·Elisabeth H. Thijssen, Renaud La Joie, Amy A. Wolf, Amelia Strom, Ping Wang, Leonardo Iaccarino, Viktoriya Bourakova, Yann Cobigo Hit paper breakdown →	2020	603
2	Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study The Lancet Neurology ·Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom, Corrina S. Fonseca, Leonardo Iaccarino, Amy A. Wolf, Salvatore Spina, Isabel Elaine Allen Hit paper breakdown →	2021	449
3	Plasma biomarkers of astrocytic and neuronal dysfunction in early‐ and late‐onset Alzheimer's disease Alzheimer s & Dementia ·Fanny M. Elahi, Kaitlin Blackstone Casaletto, Renaud La Joie, Samantha M. Walters, Danielle Jenine Harvey, Amy A. Wolf, Lauren Edwards, Wilfredo Rivera Contreras	2019	205
4	Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome JAMA Neurology ·Richard M. Tsai, Zachary Miller, MARY E. KOESTLER, Julio C. Rojas, Peter Alexander Ljubenkov, Howard J. Rosen, Gil Dan Rabinovici, Anne M. Fagan	2019	114
5	Temporal order of clinical and biomarker changes in familial frontotemporal dementia Nature Medicine ·Adam M. Staffaroni, Melanie Quintana, Barbara A. Wendelberger, Hilary W. Heuer, Lucy Louise Russell, Yann Cobigo, Amy A. Wolf, Sheng‐Yang M. Goh	2022	104
6	Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration Neurology ·Julio C. Rojas, Ping Wang, Adam M. Staffaroni, Carolin Heller, Yann Cobigo, Amy A. Wolf, Sheng‐Yang M. Goh, Peter Alexander Ljubenkov	2021	81
7	A longitudinal characterization of perfusion in the aging brain and associations with cognition and neural structure Human Brain Mapping ·Adam M. Staffaroni, Yann Cobigo, Fanny M. Elahi, Kaitlin Blackstone Casaletto, Samantha M. Walters, Amy A. Wolf, Cutter Augustus Lindbergh, Howard J. Rosen	2019	70
8	Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve Alzheimer s & Dementia ·Ignacio Illán‐Gala, Kaitlin Blackstone Casaletto, Sergi Borrego‐Écija, Eider M. Arenaza‐Urquijo, Amy A. Wolf, Yann Cobigo, Sheng‐Yang M. Goh, Adam M. Staffaroni	2021	54
9	Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy Movement Disorders Clinical Practice ·Lawren A. VandeVrede, Marian L. Dale, Scott Fields, Megan Frank, Emma B. Hare, Hilary W. Heuer, Kellie Keith, MARY E. KOESTLER	2020	51
10	An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury PLoS ONE ·Marie Altendahl, Pauline Maillard, Danielle Jenine Harvey, Devyn L. Cotter, Samantha M. Walters, Amy A. Wolf, Baljeet Singh, Visesha Kakarla	2020	51
11	Cognitive aging is not created equally: differentiating unique cognitive phenotypes in “normal” adults Neurobiology of Aging ·Kaitlin Blackstone Casaletto, Fanny M. Elahi, Adam M. Staffaroni, Samantha M. Walters, Wilfredo Rivera Contreras, Amy A. Wolf, Dena B. Dubal, Bruce L. Miller	2019	47
12	Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females Neurobiology of Aging ·Lauren Edwards, Renaud La Joie, Leonardo Iaccarino, Amelia Strom, Suzanne L. Baker, Kaitlin Blackstone Casaletto, Yann Cobigo, Harli E. Grant	2021	46
13	Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint Alzheimer s & Dementia ·Adam M. Staffaroni, Lynn P. Bajorek, Kaitlin Blackstone Casaletto, Yann Cobigo, Sheng‐Yang M. Goh, Amy A. Wolf, Hilary W. Heuer, Fanny M. Elahi	2019	42
14	Systemic Tumor Necrosis Factor-Alpha Trajectories Relate to Brain Health in Typically Aging Older Adults The Journals of Gerontology Series A ·Cutter Augustus Lindbergh, Kaitlin Blackstone Casaletto, Adam M. Staffaroni, Fanny M. Elahi, Samantha M. Walters, Michelle Y. You, John M Neuhaus, Will Rivera Contreras	2019	41
15	Get Moving! Increases in Physical Activity Are Associated With Increasing Functional Connectivity Trajectories in Typically Aging Adults Frontiers in Aging Neuroscience ·Karen A. Dorsman, Sophia Weiner‐Light, Adam M. Staffaroni, Jesse A. Brown, Amy A. Wolf, Yann Cobigo, Samantha M. Walters, Joel H. Kramer	2020	29
16	Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT , GRN , and C9orf72 Pathogenic Variants JAMA Network Open ·Adam M. Staffaroni, Sheng‐Yang M. Goh, Yann Cobigo, Elise Ong, Suzee E. Lee, Kaitlin Blackstone Casaletto, Amy A. Wolf, Leah K. Forsberg	2020	28
17	Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults Alzheimer s & Dementia ·Rowan Saloner, Lawren A. VandeVrede, Breton Michael Asken, Emily W. Paolillo, Eva Q. Gontrum, Amy A. Wolf, Argentina Lario‐Lago, Marta Milà‐Alomà	2023	28
18	Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Fanny M. Elahi, Bright S. Ashimatey, Samantha M. Walters, Renaud La Joie, Xuejuan Jiang, Amy A. Wolf, Yann Cobigo, Adam M. Staffaroni	2021	27
19	REM sleep is associated with white matter integrity in cognitively healthy, older adults PLoS ONE ·Marie Altendahl, Devyn L. Cotter, Adam M. Staffaroni, Amy A. Wolf, Paige Mumford, Yann Cobigo, Kaitlin Blackstone Casaletto, Fanny M. Elahi	2020	25
20	Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration JAMA Network Open ·Ignacio Illán‐Gala, Neus Falgàs, Adit Friedberg, Sheila Castro‐Suárez, Ophir Keret, Didem Öz, Salvatore Lo Nigro, Andrea Quattrone	2021	20

About Amy A. Wolf

Amy A. Wolf is a scholar working on Psychiatry and Mental health, Neurology, Physiology, Neuropsychology and Physiological Psychology and Cognitive Neuroscience, having authored 40 papers that have together received 2.2k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (27 papers), Alzheimer's disease research and treatments (7 papers), Amyotrophic Lateral Sclerosis Research (6 papers), Aging and Gerontology Research (2 papers), Sleep and related disorders (1 paper), Advanced Neuroimaging Techniques and Applications (1 paper), Sleep and Wakefulness Research (1 paper) and Memory Processes and Influences (1 paper). The work is most often cited by research in Psychiatry and Mental health (1.3k citations), Physiology (804 citations), Neurology (286 citations), Neurology (113 citations) and Aging (13 citations). Amy A. Wolf has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Joel H. Kramer, Kaitlin Blackstone Casaletto, Samantha M. Walters, Fanny M. Elahi, Yann Cobigo, Howard J. Rosen, Bruce L. Miller, Adam M. Staffaroni, Gil Dan Rabinovici and Renaud La Joie. Their work appears in journals such as Alzheimer s & Dementia, Neurology, JAMA Network Open, Frontiers in Aging Neuroscience and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Amy A. Wolf

Impact in

Papers in i

In The Last Decade

Amy A. Wolf

Amy A. Wolf's Hit Papers

Peers

Countries citing papers authored by Amy A. Wolf

Fields of papers citing papers by Amy A. Wolf

All Works

About Amy A. Wolf

Explore authors with similar magnitude of impact

Papers in